Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.

IT injections of 2 μg/10 μl ProTX-II produced a highly significant reduction in phase I and phase II flinching compared to vehicle treated rats ( Fig. 1 ) without any severe effect on motor function ( Supplementary Table 1 ).

also in 132,142 other papers